NCT07049380View on ClinicalTrials.gov

Post-Operative Analgesic Effect of Tramadol and Nalbuphine in Smoker and Non-Smoker Patients in LC

Active, not recruitingOBSERVATIONAL

Enrollment

132

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

February 28, 2026

Conditions

Laparocele

Interventions

DIAGNOSTIC_TEST

Comparative cross sectional

evaluating the efficacy of two analgesics, tramadol and nalbuphine. The primary objectives are to estimate pain severity in smokers versus nonsmokers and identify the effect of tramadol and nalbuphine between these groups

Trial Locations (1)

Unknown

Allama Iqbal Teaching hospital, Dera Ghazi Khan

All Listed Sponsors

lead

Superior University

OTHER

NCT07049380 - Post-Operative Analgesic Effect of Tramadol and Nalbuphine in Smoker and Non-Smoker Patients in LC | Biotech Hunter | Biotech Hunter